arrow
M

Michael H. Malim

king's college london
H指数:92
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison

SARS-CoV-2抗体应答动力学及中和表型在轻度COVID-19中的地理差异:来自英国-乌干达比较的启示

2025-03-210
OA
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

初始SARS-CoV-2 A.23.1暴露的长期免疫后果: 乌干达队列中抗体反应和交叉中和的纵向研究

2025-01-290
OAAI
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
2024-09-190
OAAI
The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study

新型冠状病毒肺炎对社区队列中认知表现的影响: 一项COVID症状研究生物库前瞻性队列研究

2023-08-0136
OAAI
Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease

基于社区的COVID和非COVID疾病谱中的代谢组学和肠道微生物组谱

2023-06-272
OAAI
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders
2023-05-100
OAAI
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies

接种SARS-CoV-2疫苗后的抗体水平: 两项英国纵向研究中疫苗接种后感染和危险因素的关联

2023-01-2415
OAAI
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
2022-04-227
OAAI